Results 1 to 10 of about 265,672 (255)

Engineered exosomes for studies in tumor immunology. [PDF]

Immunol Rev, 2022
Alptekin A, Parvin M, Chowdhury HI, Rashid MH, Arbab AS.   +4 more
europepmc   +1 more source

Evodiamine inhibits colorectal cancer cell stemness by disturbing ubiquitin specific protease 4 mediated SOX9 stabilization

Discover Oncology
Colorectal cancer (CRC) is the third most common cancer and the second most deadly cancer worldwide. It is of great importance to explore new mechanisms and therapeutic targets.
Siqi Chen, Jinfeng Yang, Guangying Qi, Jiawei Zhao, Yujing Chen, Xiaotong Guo, Juzheng Zhang, Jinfeng Gan, Zhiyuan Jian, Jiamin Jin   +9 more
doaj   +1 more source

Verteporfin inhibits the cGAS-STING pathway and improves the tumor microenvironment during cisplatin treatment in hepatocellular carcinoma

Frontiers in Immunology
BackgroundCisplatin (DDP) is a clinical first-line chemotherapy drug for hepatocellular carcinoma (HCC), but treatment is often ineffective due to drug resistance.
Yi Gong, Yi Gong, Yajun Xiong, Yuting Gao, Xiaoyong Song, Yanli Gong, Dan Wang, Zhihan Liu, Yanguang Yang, Yanguang Yang, Junlan Lu, Junlan Lu, Isabelle Xinyue Zou, Xinli Shi, Xinli Shi   +14 more
doaj   +1 more source

Epigenetics of Dendritic Cells in Tumor Immunology. [PDF]

Cancers (Basel), 2022
Godoy-Tena G, Ballestar E.
europepmc   +1 more source

Tumor immunology CRISPR screening: present, past, and future. [PDF]

Trends Cancer, 2022
Dong MB, Tang K, Zhou X, Zhou JJ, Chen S.   +4 more
europepmc   +1 more source

Lung cancer in never smokers: Tumor immunology and challenges for immunotherapy. [PDF]

Front Immunol, 2022
de Alencar VTL, Figueiredo AB, Corassa M, Gollob KJ, Cordeiro de Lima VC.   +4 more
europepmc   +1 more source

Characterization of tumor microenvironment and tumor immunology based on the double-stranded RNA-binding protein related genes in cervical cancer. [PDF]

J Transl Med, 2023
Li J, Wan C, Li X, Quan C, Li X, Wu X.
europepmc   +1 more source

Exosomes reveal the dual nature of radiotherapy in tumor immunology. [PDF]

Cancer Sci, 2022
Hu X, Qiu Y, Zeng X, Wang H.
europepmc   +1 more source

Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy resistance. [PDF]

Front Immunol, 2022
Ganjoo S, Puebla-Osorio N, Nanez S, Hsu E, Voss T, Barsoumian H, Duong LK, Welsh JW, Cortez MA.   +8 more
europepmc   +1 more source

Tumor Immunology and Immunotherapy of Non-Small-Cell Lung Cancer. [PDF]

Cold Spring Harb Perspect Med, 2022
Cascone T, Fradette J, Pradhan M, Gibbons DL.   +3 more
europepmc   +1 more source